About Gurubaba Pharmax Private Limited
Data last updated:
Gurubaba Pharmax Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52200MH2017PTC292286. Its GSTIN is 27AAGCG7375K1Z1 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepak Prakash Krishnani and Rama Deepak Krishnani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 591 A Deshpande Layout, Nagpur, Maharashtra, India – 440008.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.5 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹9.26 Lakh (net margin 19.1%) and EBITDA of ₹9.26 Lakh (EBITDA margin 19.1%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website edmedsindia.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address591 A Deshpande Layout, Nagpur, Maharashtra, India – 440008
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gurubaba Pharmax Private Limited
The main business activity of Gurubaba Pharmax is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gurubaba Pharmax Private Limited FY 2025 filings available
Gurubaba Pharmax Private Limited reported revenue of ₹48.5 Lakh (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Gurubaba Pharmax Private Limited
Revenue rose 32% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 22%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gurubaba Pharmax Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.26 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.26 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gurubaba Pharmax Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 19.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gurubaba Pharmax are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gurubaba Pharmax Private Limited
Gurubaba Pharmax Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stargenics India Private Limited | ₹48.77 Lakh (FY 2024) | •••• | •••• | 21.0% | •••• | Thane, Maharashtra, India |
| Manomay Life Care Private Limited | ₹48.74 Lakh (FY 2025) | •••• | •••• | 36.0% | •••• | Ranchi, Jharkhand, India |
| Clouds M Pharmaz Private Limited | ₹48.73 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Patna, Bihar, India |
| Mgees Holitel Hotels Private Limited | ₹48.72 Lakh (FY 2025) | •••• | •••• | -31.0% | •••• | New Delhi, Delhi, India |
| Kosvo Pharmaceuticals India Private Limited | ₹48.59 Lakh (FY 2025) | •••• | •••• | -53.0% | •••• | Agra, Uttar Pradesh, India |
| Gurubaba Pharmax Private Limited this company | ₹48.5 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | Nagpur, Maharashtra, India |
| Beemed Pharma Solutions Private Limited | ₹48.5 Lakh (FY 2025) | •••• | •••• | 345.0% | •••• | New Delhi, Delhi, India |
| Optimus Lifecare Private Limited | ₹48.48 Lakh (FY 2024) | •••• | •••• | 25.0% | •••• | Meerut, Uttar Pradesh, India |
| Swati Manufacturers Private Limited | ₹48.46 Lakh (FY 2025) | •••• | •••• | -83.0% | •••• | New Delhi, Delhi, India |
| Healease Pharma Private Limited | ₹48.45 Lakh (FY 2025) | •••• | •••• | •••• | Jaipur, Rajasthan, India | |
| Adino Life Pharmaceuticals Private Limited | ₹48.32 Lakh (FY 2016) | •••• | •••• | -14.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Gurubaba Pharmax by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Gurubaba Pharmax Private Limited
Gurubaba Pharmax Private Limited is audited by AMIT BHAGYAWANI & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AMIT BHAGYAWANI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gurubaba Pharmax Private Limited
Gurubaba Pharmax has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Prakash Krishnani | Director | 10 Mar 2017 | 9 Years 7 Months | Current |
| Rama Deepak Krishnani | Director | 10 Mar 2017 | 9 Years 7 Months | Current |
Ownership and Shareholding of Gurubaba Pharmax Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gurubaba Pharmax Private Limited
Gurubaba Pharmax Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Gurubaba Pharmax Private Limited
Employment history and EPFO contributions of people linked to Gurubaba Pharmax.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gurubaba Pharmax Private Limited
Gurubaba Pharmax Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Anilkumar Nanakram Gangwani ceased to be Director on 05 Jan 2021.
Credit Ratings, Litigation & Regulatory Alerts for Gurubaba Pharmax Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gurubaba Pharmax Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gurubaba Pharmax Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gurubaba Pharmax Private Limited
Gurubaba Pharmax has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCG7375K1Z1 | Maharashtra | Active | 08 May 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gurubaba Pharmax Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gurubaba Pharmax Private Limited
Gurubaba Pharmax is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 March 2017 (9+ years old) and is registered under CIN U52200MH2017PTC292286.
Gurubaba Pharmax reported revenue of ₹48.5 Lakh for FY 2025 (up 32% YoY).
Gurubaba Pharmax has 2 current directors:
- Deepak Prakash Krishnani - Director
- Rama Deepak Krishnani - Director
Gurubaba Pharmax reported a net profit of ₹9.26 Lakh (net margin 19.1%) and EBITDA of ₹9.26 Lakh (EBITDA margin 19.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gurubaba Pharmax is -22% over three years. In the latest year (FY 2025) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gurubaba Pharmax is 27AAGCG7375K1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Gurubaba Pharmax is U52200MH2017PTC292286. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gurubaba Pharmax was incorporated on 10 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Gurubaba Pharmax by revenue are Stargenics India Private Limited, Manomay Life Care Private Limited, Clouds M Pharmaz Private Limited, Mgees Holitel Hotels Private Limited, Kosvo Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Anilkumar Nanakram Gangwani ceased to be Director on 05 Jan 2021. Divya Anilkumar Gangwani ceased to be Director on 05 Jan 2021. Aerik Sureshkumar Wadhwani ceased to be Director on 01 May 2017. Gurubaba Pharmax has 5 board changes on record in total.
Gurubaba Pharmax can be reached through the website edmedsindia.com. Its registered office is in Nagpur, Maharashtra, India.